Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials
Author(s) -
Μenelaos Zafrakas,
Panayiota Papasozomenou,
Christos Emmanouilides
Publication year - 2016
Publication title -
world journal of clinical oncology
Language(s) - English
Resource type - Journals
ISSN - 2218-4333
DOI - 10.5306/wjco.v7.i4.331
Subject(s) - sorafenib , medicine , capecitabine , breast cancer , oncology , bevacizumab , anastrozole , ixabepilone , vinorelbine , clinical trial , gemcitabine , cancer , metastatic breast cancer , tamoxifen , chemotherapy , hepatocellular carcinoma , colorectal cancer , cisplatin
To evaluate the current role of sorafenib, an oral multikinase inhibitor in the treatment of breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom